Moderna (MRNA) Net Income Growth (1y) (2018 - 2026)
Moderna (MRNA) Net Income Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Moderna | 21.94 Bn | 16.73 Bn | -566.00 Mn | -38.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.31% |
| Dec 31, 2025 | 26.25% |
| Sep 30, 2025 | -1,638.46% |
| Jun 30, 2025 | 35.50% |
| Mar 31, 2025 | 17.36% |
| Dec 31, 2024 | -616.13% |
| Sep 30, 2024 | 100.36% |
| Jun 30, 2024 | 7.32% |
| Mar 31, 2024 | -1,587.34% |
| Dec 31, 2023 | -85.19% |
| Sep 30, 2023 | -448.03% |
| Jun 30, 2023 | -162.81% |
| Mar 31, 2023 | -97.84% |
| Dec 31, 2022 | -69.91% |
| Sep 30, 2022 | -68.71% |
| Jun 30, 2022 | -20.97% |
| Mar 31, 2022 | 199.51% |
| Dec 31, 2021 | 1,883.15% |
| Sep 30, 2021 | 1,530.47% |
| Jun 30, 2021 | 2,476.07% |